Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cingulate
(NASDAQ:CING)
Intraday
$0.9085
0.0685
[8.15%]
After-Hours
$0.9085
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.9085
0.0685
[8.15%]
At close: Apr 26
$0.9085
0
[0.00%]
After Hours: 8:20AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Cingulate Stock (NASDAQ:CING)
Cingulate Stock (NASDAQ: CING)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 7, 2024, 12:31PM
Monday, February 05, 2024
Peering Into Cingulate's Recent Short Interest
Benzinga Insights
-
Feb 5, 2024, 9:45AM
Friday, February 02, 2024
S&P 500 Gains Over 1%; Amazon Earnings Top Expectations
Avi Kapoor
-
Feb 2, 2024, 2:32PM
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Feb 2, 2024, 1:18PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Feb 2, 2024, 12:31PM
Cingulate shares are trading lower after the company announced pricing of a $7.5 million public offering.
Benzinga Newsdesk
-
Feb 2, 2024, 12:25PM
Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings
Avi Kapoor
-
Feb 2, 2024, 12:08PM
Dow Falls 150 Points; US Economy Adds 353,000 Jobs In January
Avi Kapoor
-
Feb 2, 2024, 9:48AM
Cingulate Announces Pricing Of $7.5M Public Offering Of 3.750M Shares At $2.00/Share
Benzinga Newsdesk
-
Feb 2, 2024, 9:22AM
Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 2, 2024, 8:21AM
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 1, 2024, 4:31PM
Monday, January 29, 2024
Cingulate Appoints Jennifer Callahan As CFO; Succeeds Lou Van Horn
Benzinga Newsdesk
-
Jan 29, 2024, 8:12AM
Cingulate Announced Werth Family Investment Associates Has Converted $3.3M Of Debt And Accrued Interest Into Cingulate Equity At A Conversion Price Of $4.785 Per Share
Benzinga Newsdesk
-
Jan 29, 2024, 6:56AM
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jan 24, 2024, 4:31PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 24, 2024, 12:31PM
Friday, January 05, 2024
HC Wainwright & Co. Maintains Buy Rating for Cingulate: Here's What You Need To Know
Benzinga Insights
-
Jan 5, 2024, 12:00PM
HC Wainwright & Co. Maintains Buy on Cingulate, Raises Price Target to $8
Benzinga Newsdesk
-
Jan 5, 2024, 7:44AM
Monday, January 01, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 1, 2024, 12:30PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jan 1, 2024, 8:05AM
Friday, December 29, 2023
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 29, 2023, 1:03PM
US Stocks Edge Higher On Last Trading Day Of 2023; Chicago PMI Falls In December
Avi Kapoor
-
Dec 29, 2023, 9:58AM
Why Titan Pharmaceuticals Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 29, 2023, 8:51AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 29, 2023, 8:05AM
Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Hovers Near Record High
Avi Kapoor
-
Dec 29, 2023, 5:50AM
Thursday, December 28, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 28, 2023, 4:31PM
Gold Moves Lower; US Crude Stocks Decline Last Week
Avi Kapoor
-
Dec 28, 2023, 2:32PM
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 28, 2023, 1:07PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Dec 28, 2023, 12:31PM
Crude Oil Down 1%; US Wholesale Inventories Fall In November
Avi Kapoor
-
Dec 28, 2023, 12:07PM
Cingulate shares are trading higher after the company announced it received guidance from the FDA regarding its clinical program for CTx-1301. Based on the guidance, the company expects to submit the NDA for CTx-1301 in the first half of 2025.
Benzinga Newsdesk
-
Dec 28, 2023, 10:18AM
Dow Gains 50 Points; US Jobless Claims Rise To 218,000
Avi Kapoor
-
Dec 28, 2023, 10:03AM
Cingulate Shares Resume Trading
Benzinga Newsdesk
-
Dec 28, 2023, 9:52AM
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
Vandana Singh
-
Dec 28, 2023, 9:50AM
Cingulate Shares Halted On Circuit Breaker To The Downside, Stock Now Up 174.2%
Benzinga Newsdesk
-
Dec 28, 2023, 9:48AM
Cingulate Shares Resume Trade
Benzinga Newsdesk
-
Dec 28, 2023, 9:47AM
Cingulate Shares Halted On Circuit Breaker To The Upside, Stock Now Up 198.8%
Benzinga Newsdesk
-
Dec 28, 2023, 9:42AM
Market-Moving News for December 28th
Benzinga Newsdesk
-
Dec 28, 2023, 8:41AM
Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 28, 2023, 8:22AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Dec 28, 2023, 8:06AM
Cingulate Said Received Notice From Nasdaq On December 26, 2023, Indicating Non-compliance With Its Independent Director And Committee Requirements Due To The Resignation Of Three Board Members
Charles Gross
-
Dec 28, 2023, 6:35AM
Cingulate Said We Received Guidance From The FDA Regarding Its Clinical Program For CTX-1301 its Lead Investigational Product Candidate For The Treatment Of ADHD. Based On This Guidance, We Expect To Submit The NA For CTX-1301 In H1 2025
Charles Gross
-
Dec 28, 2023, 6:29AM
Wednesday, December 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Dec 27, 2023, 4:31PM
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 27, 2023, 2:11PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Dec 27, 2023, 12:31PM
US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY
Avi Kapoor
-
Dec 27, 2023, 9:56AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Dec 27, 2023, 8:07AM
Friday, December 22, 2023
Laidlaw & Co. Downgrades Cingulate to Hold
Benzinga Newsdesk
-
Dec 22, 2023, 4:42AM
Tuesday, December 19, 2023
Maxim Group Downgrades Cingulate to Hold
Benzinga Newsdesk
-
Dec 19, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Dec 19, 2023, 8:07AM
Monday, December 18, 2023
Maxim Group Downgrades Cingulate to Hold
Benzinga Newsdesk
-
Dec 18, 2023, 11:37AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch